10 years ago

DNAe Secures £25 Million Bank Facility from Citibank

  • DNAe, a London-based developer of semiconductor DNA sequencing technology, has secured a £25 million bank facility from Citibank

  • The company will use the funds to complete the development of its point-of-need test for serious blood infections, which includes clinical trials targeted for 2016 and product launch in 2017

  • DNAe is backed by international investors, including major shareholder Genting Berhad.

      • ProblemHealthcare

      "Current blood infection testing methods take a long time to provide results, leading to delayed treatment and increased risk of sepsis."

      Solution

      "DNAe is developing a rapid, point-of-need test that uses semiconductor DNA sequencing technology to detect serious blood infections in 2-3 hours, enabling faster diagnosis and treatment."

      Covered on